Genomic organization of the human p57KIP2 gene and its analysis in the G401 Wilms' tumor assay

Cancer Research

Volumn 56, Issue 6, 1996, Pages 1214-1218

  Reid, Laura Hink ^a   Crider Miller, Shyra J ^a   West, Ande ^a   Lee, Mong Hong ^b   Massagué, Joan ^b   Weissman, Bernard E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CANCER GENETICS; DNA DETERMINATION; DNA SEQUENCE; GENETIC ANALYSIS; GENOME; HUMAN; HYBRID CELL; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; CRICETINAE; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DNA, COMPLEMENTARY; GENE DELETION; GENES; GENES, WILMS TUMOR; HUMANS; HYBRID CELLS; KIDNEY NEOPLASMS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; WILMS TUMOR;

EID: 0029897682     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hunter, T , and Pines, J Cyclins and cancer II cyclin D and CDK inhibitors come of age. Cell, 79. 573-582, 1994.
2. Cordon-Cardo, C. Mutation of cell cycle regulators, biological and clinical implications for human neoplasia. Am. J Pathol , 147: 545-560, 1995.
3. MacLachlan, T. K., Sang, N., and Giordano, A. Cyclins, cyclin-dependent kinases and cdk inhibitors, implications in cell cycle control and cancer Crit. Rev. Eukaryotic Gene Expr., 5: 127-156, 1995.
4. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes & Dev., 9: 639-649, 1995.
5. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes & Dev., 9. 650-662, 1995.
6. Seizinger, B. R. Klinger, H P., Junien, C , Nakamura, Y , Le Beau, M., Cavenee, W., Emanuel, B., Ponder, B., Naylor, S., Mitelman, F., Louis, D., Menon, A., Newsham, I , Decker, J., Kaelbling, M., Henry, I , and Deimling, A v. Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet. Cell Genet., 58: 1080-1096, 1991.
7. Sait, S. N. J., Nowak, N. J., Singh-Kahlon, P , Weksberg, R., Squire, J., Shows, T. B., and Higgins, M. J. Localization of Beckwith-Wiedemann and rhabdoid tumor chromosome rearrangements to a defined interval in chromosome band 11p15.5. Genes Chromosomes & Cancer, 11: 97-105, 1994.
8. Hoovers, J. M N., Kalikin, L M., Johnson, L. A., Alders, M., Redeker, B , Law, D. J., Bliek, J., Steenman, M., Benedict, M., Wiegant, J., Lengauer, C., Taillon-Miller, P., Schlessinger, D., Edwards, M. C., Elledge, S. J., Ivens, A., Westerveld, A., Little, P., Mannens, M , and Feinberg, A. P. Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc Natl. Acad. Sci. USA, 92: 12456-12460, 1995.
9. Weissman, B. E., Saxon, P J., Pasquale, S R., Jones, G. R., Geiser, A. G., and Stanbridge, E. J. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science (Washington DC), 236: 175-180, 1987.
10. Dowdy, S F , Fasching, C. L., Araujo, D., Lai, K-M., Livanos, E , Weissman, B. E , and Stanbridge, E. J. Suppression of tumongenicity in Wilms' tumor by the p15 5-p14 region of chromosome II. Science (Washington DC), 254. 293-295, 1991.
11. Reid, L H , West, A , Gioeli, D. G., Phillips, K. K., Kelleher, K. F., Araujo, D., Stanbridge, E. J., Dowdy, S. F., Gerhard, D. S., and Weissman, B. E. Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay. Hum. Mol. Genet., in press, 1996
12. Koi, M., Johnson, L. A , Kalikin, L. M., Little, P. F. R., Nakamura, Y., and Feinberg, A P. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11 Science (Washington DC), 260. 361-364, 1993.
13. Gerhard, D S., Jones, C , Morse, H. G., Handelin, B., Weeks, V., and Housman, D. Analysis of human chromosome 11 by somatic cell genetics: reexamination of derivatives of human-hamster cell line J1. Somat. Cell Mol Genet., 13. 293-304, 1987.
14. Glaser, T., Housman, D., Lewis, W. H , Gerhard, D., and Jones, C. A fine-structure deletion map of human chromosome 11p: analysis of J1 series hybrids. Somat. Cell Mol. Genet., 15: 477-501, 1989.
15. Dowdy, S. F., Scanlon, D J , Fasching, C. L., Casey, G., and Stanbridge, E. J. Irradiation microcell-mediated chromosome transfer (XMMCT): the generation of specific chromosomal arm deletions. Genes Chromosomes & Cancer, 2. 318-327, 1990.
16. Peebles, P. T., Trisch, T., and Papageorge, A. G. Isolation of four unusual pediatric solid tumor cell lines Pediatr. Res., 12: 485, 1978.
17. Tanigami, A., Tokino, T., Takiguchi, S., Mori, M., Glaser, T., Park, J W., Jones, C., and Nakamura, Y. Mapping of 262 DNA markers into 24 intervals on human chromosome 11. Am J. Hum. Genet., 50: 56-64, 1992
18. Schroeder, W. T., Chao, L. Y., Dao, D. D., Strong, L. C., Pathak, S , Riccardi, V., Lewis, W. H., and Saunders, G. F. Nonrandom loss of maternal chromosome 11 alleles in Wilms' tumors. Am. J. Hum. Genet., 40: 413-420, 1987.
19. Mannens, M., Slater, R M., Heyting, C., Bliek, J., de Kraker, J., Coad, N., de Pagter-Holthuizen, P., and Pearson, P. L Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumors. Hum. Genet., 81. 41-48, 1988.
20. Scrable, H., Cavenee, W., Ghavimi, F., Lovell, M., Morgan, K., and Sapienza, C. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc. Natl. Acad. Sci. USA, 86: 7480-7484, 1989.
21. Williams, J. C., Brown, K. W., Mott, M. G., and Maitland, N. J. Maternal allele loss in Wilms' tumour. Lancet, 1: 283-284, 1989.
22. Mannens, M., Hoovers, J. M. N., Redeker, B., Verjaal, M., Feinberg, A. P., Little, P., Boavida, M , Coad, N., Steenman, M., Bliek, J., Niikawa, N , Tonoki, H., Nakamura, Y., de Boer, E. G., Slater, R. M., John, R., Cowell, J. K., Junien, C., Henry, I., Tommerup, N., Weksberg, R., Pueschel, S M., Leschot, N. J., and Westerveld, A. Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasm. Eur. J. Hum Genet., 2 3-23, 1994.
23. Zhang, Y., and Tycko, B. Monoallelic expression of the human H19 gene Nat. Genet., 1: 40-44, 1992.
24. Giannoukakis, N , Deal, C., Pacquette, J., Goodyer, C., and Polychronakos, C. Parental genomic imprinting of the human IGF2. Nat. Genet., 4: 98-101, 1993.
25. Ohlsson, R., Nystrom, A., Pfeifer-Ohlsson, S , Tohonen, V., Hedborg, F., Schofield, P., Flam, F., and Ekstrom, T. J. IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome Nat. Genet , 4: 94-97, 1993.
26. Rainier, S., Johnson, L. A., Dobry, C. J., Ping, A. J., Grundy, P. E , and Feinberg, A. P. Relaxation of imprinted genes in human cancer Nature (Lond.), 362: 747-749, 1993.
27. Ogawa, O., Eccles, M. R., Szeto, J., McNoe, L. A., Yun, K., Maw, M. A., Smith, P J., and Reeve, A E. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumor Nature (Lond.), 362: 749-751, 1993.
28. Bartolomei, M. S , Webber, A. L., Brunkow, M. E , and Tilghman, S. M. Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes & Dev., 7: 1663-1673, 1993.
29. Zhang, Y., Shields, T., Crenshaw, T , Hao, Y., Moulton, T., and Tycko, B. Imprinting of human H19: allele-specific CpG methylation, loss of active allele in Wilms tumor, and potential for somatic allele switching. Am. J. Hum. Genet., 53. 113-124, 1993.
30. Weksberg, R., Shen, D. R., Fei, Y. L., Song, Q. L., and Squire, J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat. Genet., 5: 143-150, 1993
31. Steenman, M. J. C., Rainier, S., Dobry, C. J., Grundy, P., Horon, I. L., and Feinberg, A. P Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. Nat Genet., 7: 433-439, 1994.
32. Moulton, T., Crenshaw, T., Hao, Y., Moosikasuwan, J., Lin, N., Dembitzer, F., Hensle, T., Weiss, L., McMorrow, L., Loew, T., Kraus, W., Gerald, W., and Tycko, B Epigenetic lesions at the H19 locus in Wilms' tumor patients. Nat Genet., 7: 440-447, 1994.
33. KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat. Genet., 11: 204-206, 1995.
34. Kamb, A Cell-cycle regulators and cancer. Trends Genet., 11: 136-140, 1995.
35. Bhatia, K., Fan, S., Spangler, G., Weintraub, M., O'Connor, P. M., Judde, J-G , and Magrath, I. A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma. Cancer Res., 55: 1431-1435, 1995
36. Gao, X., Chen, Y. Q., Wu, N., Grignon, D. J., Sakr, W., Porter, A. T , and Honn, K. V. Somatic mutations of the WAFI/CIP1 gene in primary prostate cancer. Oncogene, 11: 1395-1398, 1995.
37. KIP1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res , 55: 1211-1214, 1995.
38. KIP1 gene to 12p13 and its analysis in leukemias. Cancer Res , 55: 1206-1210, 1995
39. KIP1, to regions involved in human cancer. Cancer Res., 55: 1199-1205, 1995
40. KIP2 in soft tissue sarcomas and Wilms' tumors. Cancer Res., 56: 1219-1221, 1996.